These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8610521)

  • 1. Adverse reactions in myelography.
    Maly P; Sundgren P; Baath L; Golman K; Walday P
    Acta Radiol Suppl; 1995; 399():230-7. PubMed ID: 8610521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective comparison of iotrolan and iohexol in lumbar myelography.
    Wagner A; Jensen C; Saebye A; Rasmussen TB
    Acta Radiol; 1994 Mar; 35(2):182-5. PubMed ID: 8172748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural tolerance of the non-ionic dimers iodixanol and iotrolan and the non-ionic monomer iopamidol during myelography in non-anaesthetised rabbits.
    Maly P; Sundgren P; Bååth L; Walday P
    Acta Radiol; 1995 Nov; 36(6):644-8. PubMed ID: 8519577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with iomeprol in myelography and myelo-CT: clinical pharmacology and double-blind comparisons with iopamidol, iohexol, and iotrolan.
    Katayama H; Heneine N; van Gessel R; Taroni P; Spinazzi A
    Invest Radiol; 2001 Jan; 36(1):22-32. PubMed ID: 11176258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iotrolan versus iopamidol: a controlled, multicenter, double-blind study of lumbar and direct cervical myelography.
    Ringel K; Klotz E; Wenzel-Hora BI
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():153-7. PubMed ID: 2568784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lumbar myelography with iohexol and metrizamide: a comparative multicenter prospective study.
    Kieffer SA; Binet EF; Davis DO; Gabrielsen TO; Kido DK; Latchaw RE; Turski PA; Shaw DD
    Radiology; 1984 Jun; 151(3):665-70. PubMed ID: 6371890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials with iotrolan in myelographic and computed tomography applications in the United States.
    Goldstein HA; Pfennig D
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():167-70. PubMed ID: 2568788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CNS-effects from subarachnoid injections of iohexol and the non-ionic dimers iodixanol and iotrolan in the rabbit.
    Sundgren P; Bååth L; Maly P
    Acta Radiol; 1995 May; 36(3):307-11. PubMed ID: 7742128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A randomized, double-blind clinical trial of 2 nonionic contrast media for myelography].
    Lovrencić M; Klanfar Z; Jakovac I
    Lijec Vjesn; 1986 Apr; 108(4):141-6. PubMed ID: 3520199
    [No Abstract]   [Full Text] [Related]  

  • 10. Iotrolan, a nonionic dimeric contrast medium in myelography.
    Bien S; Schumacher M; Berger W; Wenzel-Hora BI
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():158-60. PubMed ID: 2568785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iotrol, a new myelographic agent: 2. Comparative electroencephalographic evaluation by spectrum analysis.
    Sovak M; Ranganathan R; Kerber CW; Bickford R; Alksne JF
    AJNR Am J Neuroradiol; 1983; 4(3):319-22. PubMed ID: 6410733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iotrolan versus iopamidol for cervical myelography: a randomized double-blind trial.
    Coutinho C; McGeorge A; Macpherson P; Teasdale E
    Br J Radiol; 1988 Oct; 61(730):965-7. PubMed ID: 3056560
    [No Abstract]   [Full Text] [Related]  

  • 13. A prospective comparison of iotrolan, iohexol and iopamidol for lumbar myelography.
    Lamb J; McAllister V; Nelson M; Bartlett R; Smith I; Deopugari CE
    Acta Radiol Suppl; 1986; 369():524-7. PubMed ID: 2980547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adverse reactions and intracranial contrast medium after myelography].
    Fujii K; Hashimoto T; Isaza M; Hashimoto T; Hirabuki N; Miura T; Mitomo M; Kozuka T; Kawai R
    Rinsho Hoshasen; 1989 Mar; 34(3):323-7. PubMed ID: 2739082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of iohexol with metrizamide in myelography.
    Sortland O; Nestvold K; Kloster R; Aandahl MH
    Radiology; 1984 Apr; 151(1):121-2. PubMed ID: 6701301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adverse reactions during ascending cervical myelography using iopamidol and metrizamide--a double-blind study].
    Bockenheimer S; Eichenlaub H
    Rontgenpraxis; 1986 May; 39(5):171-4. PubMed ID: 3523789
    [No Abstract]   [Full Text] [Related]  

  • 17. Ioglucomide: a new nonionic myelographic agent. Preclinical studies.
    Hopkins RM; Adams MD; Lau DH; Creighton JM; Hoey GB
    Radiology; 1981 Sep; 140(3):713-7. PubMed ID: 7280240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iohexol: summary of North American and European clinical trials in adult lumbar, thoracic, and cervical myelography with a new nonionic contrast medium.
    Shaw DD; Bach-Gansmo T; Dahlstrom K
    Invest Radiol; 1985; 20(1 Suppl):S44-50. PubMed ID: 3882616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison in myelography between iodixanol 270 and 320 mgI/ml and iotrolan 300 mgI/ml: a multicentre, randomised, parallel-group, double-blind, phase III trial.
    Palmers Y; Kuhn FP; Petersen D; De Greef D
    Eur Radiol; 2002 Mar; 12(3):686-91. PubMed ID: 11870488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iohexol versus metrizamide for lumbar myelography: double-blind trial.
    Gabrielsen TO; Gebarski SS; Knake JE; Latack JT; Yang PJ; Hoff JT
    AJR Am J Roentgenol; 1984 May; 142(5):1047-9. PubMed ID: 6372410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.